Tapewire

Nasdaq · USD

ALXO

ALX ONCOLOGY HOLDINGS INC

Export transactions ↓
Tapewire entity
6040
SEC CIK
0001810182
Parsed reports
213

Last 12 months

Inside the activity.

1 purchase rows · 7 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202601
Feb 202611
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202601
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 17, 2026 Filed Aug 18, 2026 21:51 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 2,230 $1.93 $4,303.90
Disclosure

SEC source: 0001193125-26-355764 · ownership.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 294,379

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026.

Read SEC document
August 17, 2026 Filed Aug 18, 2026 21:50 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 573 $1.93 $1,105.89
Disclosure

SEC source: 0001193125-26-355761 · ownership.xml · nonDerivative · entry 1

Wong Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,828

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
July 01, 2026 Filed Jul 6, 2026 20:30 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 1,404 $2.04 $2,864.16
Disclosure

SEC source: 0001193125-26-296246 · ownership.xml · nonDerivative · entry 1

Wong Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,401

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.02 to $2.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2026.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 20:15 UTC
Knight Jeff E.Chief Dev & Operating Officer
GrantStock option (right to buy) · Derivative 800,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001193125-26-161558 · ownership.xml · derivative · entry 1

Knight Jeff E. · CIK 0001881007 · Chief Dev & Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 800,000

Underlying: Common Stock · 800,000 shares

Expires 2036-04-15

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on April 13, 2027 and 1/48th vest monthly thereafter.

Read SEC document
April 16, 2026 Filed Apr 17, 2026 20:15 UTC
Klencke BarbaraChief Medical Officer
GrantStock option (right to buy) · Derivative 100,000 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0001193125-26-161557 · ownership.xml · derivative · entry 1

Klencke Barbara · CIK 0001647647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2036-04-15

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 20:05 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 12,311 $2.17 $26,714.87
Disclosure

SEC source: 0001193125-26-119705 · ownership.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,609

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units.

Read SEC document
March 19, 2026 Filed Mar 23, 2026 20:05 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 903 $2.17 $1,959.51
Disclosure

SEC source: 0001193125-26-119703 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,805

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of perfomance-based restricted stock units.

Read SEC document
March 03, 2026 Filed Mar 5, 2026 21:05 UTC
Klencke BarbaraChief Medical Officer
GrantStock option (right to buy) · Derivative 700,000 $0.00 Strike: $2.07 $0.00
Disclosure

SEC source: 0001193125-26-093913 · ownership.xml · derivative · entry 1

Klencke Barbara · CIK 0001647647 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 700,000

Underlying: Common Stock · 700,000 shares

Expires 2036-03-02

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on February 25, 2027 and 1/48th vest monthly thereafter.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:01 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 565 $2.27 $1,282.55
Disclosure

SEC source: 0001193125-26-061313 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,708

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 02:02 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
Tax withholdingCommon Stock 2,201 $2.27 $4,996.27
Disclosure

SEC source: 0001193125-26-060037 · ownership.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,920

F1 · kind: The shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.

F2 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025.

Read SEC document
February 02, 2026 Filed Feb 4, 2026 21:15 UTC
GOODMAN COREY SDirector · 10% owner
PurchaseCommon Stock 3,184,713 $1.57 $4,999,999.41
Disclosure

SEC source: 0001278411-26-000002 · form4-02042026_090252.xml · nonDerivative · entry 1

GOODMAN COREY S · CIK 0001278411 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 8,453,038

F1 · ownership.nature: The shares are held of record by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. The reporting person, a director of venBio Global Strategic GP II, Ltd., disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 16:30 UTC
Shantharam HarishChief Financial Officer
GrantStock option (right to buy) · Derivative 303,000 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001193125-26-027290 · ownership.xml · derivative · entry 1

Shantharam Harish · CIK 0001976391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,000

Underlying: Common Stock · 303,000 shares

Expires 2036-01-25

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 21:30 UTC
Wong ShellySVP, FINANCE AND CAO
GrantStock option (right to buy) · Derivative 192,000 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001193125-26-027288 · ownership.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,000

Underlying: Common Stock · 192,000 shares

Expires 2036-01-25

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.

Read SEC document
January 26, 2026 Filed Jan 28, 2026 21:30 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
GrantStock option (right to buy) · Derivative 912,000 $0.00 Strike: $1.48 $0.00
Disclosure

SEC source: 0001193125-26-027287 · ownership.xml · derivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 912,000

Underlying: Common Stock · 912,000 shares

Expires 2036-01-25

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 26, 2026.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 21:30 UTC
GOODMAN COREY SDirector · 10% owner
GrantStock Option (right to buy) · Derivative 40,400 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001193125-26-018039 · ownership.xml · derivative · entry 1

GOODMAN COREY S · CIK 0001278411 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2036-01-19

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 21:30 UTC GrantStock option (right to buy) · Derivative 10,100 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001193125-26-018028 · ownership.xml · derivative · entry 1

Sandler Alan B. · CIK 0001835966 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,100

Underlying: Common Stock · 10,100 shares

Expires 2036-01-19

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 21:30 UTC GrantStock option (right to buy) · Derivative 40,400 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001193125-26-018037 · ownership.xml · derivative · entry 1

Garland J. Scott · CIK 0001533228 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2036-01-19

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 21:30 UTC GrantStock Option (right to buy) · Derivative 16,833 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001193125-26-018023 · ownership.xml · derivative · entry 1

Curran Daniel J. · CIK 0001887599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,833

Underlying: Common Stock · 16,833 shares

Expires 2036-01-19

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 21:30 UTC GrantStock option (right to buy) · Derivative 40,400 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001193125-26-018021 · ownership.xml · derivative · entry 1

Hemrajani Rekha · CIK 0001771213 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2036-01-19

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 21:30 UTC GrantStock option (right to buy) · Derivative 40,400 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0001193125-26-018022 · ownership.xml · derivative · entry 1

Takimoto Chris H · CIK 0001743780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2036-01-19

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 20, 2026.

Read SEC document
January 06, 2026 Filed Jan 7, 2026 21:30 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 3,925 $1.11 $4,356.75
Disclosure

SEC source: 0001193125-26-006374 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,273

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.11 to $1.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2025.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 16:01 UTC
Shantharam HarishChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 198,750 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001193125-25-241380 · ownership.xml · derivative · entry 1

Shantharam Harish · CIK 0001976391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,750

Underlying: Common Stock · 198,750 shares

Expires 2035-10-14

F1 · derivative.exercise_date: One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:01 UTC
Wong ShellySVP, FINANCE AND CAO
GrantEmployee Stock Option (right to buy) · Derivative 140,000 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001193125-25-241382 · ownership.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Common Stock · 140,000 shares

Expires 2035-10-14

F1 · derivative.exercise_date: One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026.

Read SEC document
October 14, 2025 Filed Oct 16, 2025 20:01 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 597,500 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001193125-25-241381 · ownership.xml · derivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 597,500

Underlying: Common Stock · 597,500 shares

Expires 2035-10-14

F1 · derivative.exercise_date: One-third of the shares subject to the option vest on April 30, 2026 and the remaining two-thirds of the option vest on October 31, 2026.

Read SEC document
September 17, 2025 Filed Sep 18, 2025 20:23 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 71,163 $1.08 $76,891.62
Disclosure

SEC source: 0001193125-25-207432 · ownership.xml · nonDerivative · entry 2

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,121

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.09, inclusive.

Read SEC document
September 17, 2025 Filed Sep 19, 2025 20:01 UTC GrantStock option (right to buy) · Derivative 300,000 $0.00 Strike: $1.05 $0.00
Disclosure

SEC source: 0001193125-25-209045 · ownership.xml · derivative · entry 1

Klencke Barbara · CIK 0001647647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Common Stock · 300,000 shares

Expires 2035-09-16

F1 · derivative.exercise_date: One-third of the shares subject to the option vest on each of September 17, 2025, January 31, 2026 and June 30, 2026.

Read SEC document
September 16, 2025 Filed Sep 18, 2025 20:23 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
PurchaseCommon Stock 21,070 $1.07 $22,460.62
Disclosure

SEC source: 0001193125-25-207432 · ownership.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 233,958

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.07, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.

Read SEC document
August 18, 2025 Filed Aug 20, 2025 16:02 UTC
Shantharam HarishChief Financial Officer
PurchaseCommon Stock 75,000 $0.78 $58,402.50
Disclosure

SEC source: 0000950170-25-110434 · ownership.xml · nonDerivative · entry 1

Shantharam Harish · CIK 0001976391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6823 to $0.9234, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:12 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 611 $0.64 $391.28
Disclosure

SEC source: 0000950170-25-110102 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,198

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2025.

Read SEC document
August 15, 2025 Filed Aug 19, 2025 20:09 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 2,382 $0.64 $1,525.43
Disclosure

SEC source: 0000950170-25-110099 · ownership.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,888

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.64 to $0.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on June 30, 2025.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 20:47 UTC GrantStock option (right to buy) · Derivative 40,400 $0.00 Strike: $0.62 $0.00
Disclosure

SEC source: 0000950170-25-108119 · ownership.xml · derivative · entry 1

Curran Daniel J. · CIK 0001887599 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2035-08-11

F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on September 12, 2025.

Read SEC document
July 07, 2025 Filed Jul 8, 2025 20:37 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 2,011 $0.45 $905.15
Disclosure

SEC source: 0000950170-25-094613 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,809

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.45 to $0.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
June 30, 2025 Filed Jul 1, 2025 20:22 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 1,532 $0.43 $658.76
Disclosure

SEC source: 0000950170-25-092232 · ownership.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 88,820

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 16:16 UTC
Shantharam HarishChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001415889-25-010690 · form4-04152025_080423.xml · derivative · entry 1

Shantharam Harish · CIK 0001976391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-04-11

F1 · derivative.exercise_date: All of the shares subject to the option vest on April 11, 2026.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 20:29 UTC
Wong ShellySVP, FINANCE AND CAO
GrantEmployee Stock Option (right to buy) · Derivative 90,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001415889-25-010697 · form4-04152025_080416.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2035-04-11

F1 · derivative.exercise_date: All of the shares subject to the option vest on April 11, 2026.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 20:19 UTC
Sandler Alan B.Chief Medical Officer
GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001415889-25-010692 · form4-04152025_080430.xml · derivative · entry 1

Sandler Alan B. · CIK 0001835966 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-04-11

F1 · derivative.exercise_date: All of the shares subject to the option vest on April 11, 2026.

Read SEC document
April 11, 2025 Filed Apr 15, 2025 20:14 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
GrantEmployee Stock Option (right to buy) · Derivative 125,000 $0.00 Strike: $0.49 $0.00
Disclosure

SEC source: 0001415889-25-010686 · form4-04152025_080459.xml · derivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2035-04-11

F1 · derivative.exercise_date: All of the shares subject to the option vest on April 11, 2026.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 20:45 UTC
Wong ShellySVP, FINANCE AND CAO
GrantCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008428 · form4-03182025_080356.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,352

F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.

Read SEC document
March 14, 2025 Filed Mar 18, 2025 20:41 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
GrantCommon Stock 42,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-25-008417 · form4-03182025_080326.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,270

F1 · shares: The reported shares are represented by performance share units, or PSUs, and were awarded upon the achievement of certain performance metrics related to the positive results for ASPEN-06 clinical trials. Shares subject to the PSU vest on March 14, 2026.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 16:23 UTC
Pons JaumePRESIDENT & CSO
SaleCommon Stock 1,326 $1.15 $1,525.17
Disclosure

SEC source: 0001415889-25-005069 · form4-02212025_090208.xml · nonDerivative · entry 1

Pons Jaume · CIK 0001816977 · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 579,388

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 21:20 UTC
Lettmann JasonDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 2,159 $1.15 $2,483.28
Disclosure

SEC source: 0001415889-25-005067 · form4-02212025_090215.xml · nonDerivative · entry 1

Lettmann Jason · CIK 0001688269 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,270

F1 · kind: The shares were sold to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

F3 · balance_after: Includes 3,000 shares acquired under the Issuer's employee stock purchase plan on December 31, 2024.

Read SEC document
February 19, 2025 Filed Feb 21, 2025 21:25 UTC
Wong ShellySVP, FINANCE AND CAO
SaleCommon Stock 550 $1.15 $632.61
Disclosure

SEC source: 0001415889-25-005071 · form4-02212025_090224.xml · nonDerivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,352

F1 · kind: The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 18:19 UTC
Shantharam HarishChief Financial Officer
GrantEmployee Stock Option (right to buy) · Derivative 600,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001969 · form4-01232025_110129.xml · derivative · entry 1

Shantharam Harish · CIK 0001976391 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 600,000

Underlying: Common Stock · 600,000 shares

Expires 2035-01-20

F1 · derivative.exercise_date: One-fourth of the shares subject to the option vest on January 21, 2026 and 1/48 of the shares vest monthly thereafter.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 18:09 UTC
Pons JaumePRESIDENT & CSO
GrantEmployee Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001961 · form4-01232025_110133.xml · derivative · entry 1

Pons Jaume · CIK 0001816977 · PRESIDENT & CSO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:32 UTC GrantStock Option (right to buy) · Derivative 40,400 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001983 · form4-01232025_110145.xml · derivative · entry 1

Hemrajani Rekha · CIK 0001771213 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:30 UTC GrantCommon Stock · Derivative 40,400 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001981 · form4-01232025_110148.xml · derivative · entry 1

Garland J. Scott · CIK 0001533228 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:29 UTC
GOODMAN COREY SDirector · 10% owner
GrantStock Option (right to buy) · Derivative 40,400 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001979 · form4-01232025_110113.xml · derivative · entry 1

GOODMAN COREY S · CIK 0001278411 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:27 UTC GrantCommon Stock (right to buy) · Derivative 40,400 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001977 · form4-01232025_110135.xml · derivative · entry 1

Takimoto Chris H · CIK 0001743780 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:24 UTC GrantStock Option (right to buy) · Derivative 40,400 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001973 · form4-01232025_110125.xml · derivative · entry 1

Klencke Barbara · CIK 0001647647 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,400

Underlying: Common Stock · 40,400 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on February 21, 2025.

Read SEC document
January 21, 2025 Filed Jan 23, 2025 23:14 UTC
Wong ShellySVP, FINANCE AND CAO
GrantEmployee Stock Option (right to buy) · Derivative 112,000 $0.00 Strike: $1.65 $0.00
Disclosure

SEC source: 0001415889-25-001965 · form4-01232025_110113.xml · derivative · entry 1

Pinto Shelly · CIK 0001857740 · SVP, FINANCE AND CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 112,000

Underlying: Common Stock · 112,000 shares

Expires 2035-01-20

F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on February 21, 2025.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.